Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.
The cold, dry air of winter brings challenges for those with chronic hand eczema. Chronic hand eczema (CHE), defined as hand ...
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...
This year’s flu season is shaping up to be a nasty one—driven by a new variant of the influenza virus that may be able to slip past our vaccine defenses. A mutated form of the influenza A strain H3N2 ...
Background: Radiation dermatitis is a significant dose-limiting toxicity of radiotherapy that compromises treatment efficacy and patient quality of life. Although topical anti-inflammatory agents and ...
Among patients with atopic dermatitis, 45% had low transferrin saturation, 37% low ferritin, and 26% reduced serum iron. HealthDay News — Iron deficiency without anemia is a common feature of moderate ...
At 4 years of treatment with tralokinumab and optional topical corticosteroid or calcineurin inhibitor use among adults with moderate to severe atopic dermatitis, the majority of patients achieved ...
Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the clinic. J&J had been evaluating JNJ-95475939, an inhibitor of IL-4 and IL-31, ...
The researchers noted that "altered iron metabolism may represent a potentially modifiable systemic correlate of the AD phenotypes." HealthDay News — Iron deficiency without anemia is a common feature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results